Close menu




June 5th, 2025 | 07:00 CEST

These ESG innovations really exist: Bayer, Deere & Company, Argo Living Soils

  • Agribusiness
  • fertilizer
  • Pharma
  • machinery
Photo credits: pexels.com

Sustainability is anything but boring: Companies such as Bayer and Deere & Company are scoring points with technological innovations that are more reminiscent of Elon Musk and SpaceX than specialists in seeds and agricultural machinery. The small Canadian agricultural company Argo Living Soils has even found a solution to completely revolutionize CO2-intensive processes in construction. We present the business models and take a look at the outlook for the three stocks.

time to read: 3 minutes | Author: Nico Popp
ISIN: BAYER AG NA O.N. | DE000BAY0017 , DEERE CO. DL 1 | US2441991054 , ARGO LIVING SOILS CORP | CA04018T3064

Table of contents:


    Deere & Company brings science fiction to the field

    When farmers use machines from Deere & Company to sow new seeds, the ExactShot™ system causes great amazement. Thanks to sensors and robot control, the system fertilizes with such precision that large amounts of fertilizer can be saved without having to accept lower yields. Almost even more revolutionary is the See & Spray technology: an AI-supported camera ensures that unwanted plants are treated with herbicide with pinpoint accuracy.** According to Deere itself, farmers have reduced their pesticide use by two-thirds with this technology, saving more than 8 million gallons of plant toxins. Precision approaches like those developed by Deere & Company reduce costs and protect soil, water, and endangered species.

    The smart farming systems are controlled via the John Deere Operations Center, a digital platform that provides real-time data on field conditions, machine utilization, and performance metrics. Farmers can monitor their operations via smartphone or PC and make data-driven decisions – from sowing time to harvest. This is not only efficient and reduces costs but is also sustainable. Analysts are giving Deere & Company's shares a good rating: Following the second quarter figures in May 2025, numerous banks have raised their price targets. Examples include JPMorgan (price target USD 540, Neutral), Barclays (USD 530, Overweight) and Raymond James (USD 560, Outperform).

    Bayer aims to become more innovative – Will acquisitions follow?

    Analyst opinions are more mixed when it comes to seed specialist Bayer – the consensus rating is "Hold." Those analysts who are more optimistic believe that the efficiency program launched last year will be successful. The core of the strategy is further innovation around sustainability: The Company plans to generate EUR 3.5 billion in additional revenue through new seed generations and more precise crop protection solutions that are more targeted and resource-efficient with the help of digital tools. Bayer plans to become as innovative as John Deere already is. Acquisitions also seem possible for the Leverkusen-based company.

    Argo Living Soils: Will this technology reduce our CO2 emissions?

    The Canadian company Argo Living Soils was founded with the aim of being a driver of innovation. The young company develops and produces organic products such as biofertilizers, worm compost, and other additives that make agricultural soils more fertile in a natural way. The business model focuses on the conversion of biomass into biochar. This biochar improves soil quality in agriculture and is considered a sustainable alternative to artificial fertilizers.

    But there is much more to the biochar produced by Argo Living Soils: the Company has developed a process to synthesize graphene from its biochar. This extremely stable carbon nanomaterial has a wide range of applications, such as an additive in asphalt to increase heat resistance or as a storage medium for hydrogen in energy systems. Argo Living Soils initially wants to use its graphene as an additive in construction and has already found partners for this. It recently entered into a research alliance with the technology company Graphene Leaders Canada with the aim of developing graphene nanoplatelets as an additive for ready-mixed concrete. The goals are to improve durability while reducing CO2 emissions in construction by around 20% through lower cement requirements. Argo Living Soils and its partners believe that this technology offers a significant lever for reducing CO2 emissions. According to the Karlsruhe Institute of Technology (KIT), concrete production is Germany's third-largest source of industrial greenhouse gas emissions.


    1,000% in one year: What is in it for investors?

    But does Argo Living Soils' approach also pay off for investors? Comparing the performance of Deere & Company and Bayer over a one-year period, the more innovative company John Deere is ahead with a return of 32.8% compared to Bayer, which lost 11% over the same period. The development of Argo Living Soils' share price, which rose by an incredible 1,061% over the course of a year, shows that the hunger for innovation is huge and that the market also offers excellent opportunities for small companies. Given its still low market capitalization of CAD 8.9 million and plans for the recently formed research alliance to deliver results by the end of the year, investors should keep an eye on ESG innovator Argo Living Soils. If the technology delivers what it promises, the Company is a takeover candidate – too many corporations are desperately looking for sustainable innovations.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author



    Related comments:

    Commented by André Will-Laudien on May 21st, 2026 | 07:10 CEST

    Undervalued – Analysts Turn Their Attention to Life Sciences: Bayer, Vidac Pharma, Novo Nordisk, and Pfizer in Focus

    • Biotechnology
    • Biotech
    • Pharma
    • LifeSciences
    • agrochemical

    DZ Bank's aggressive price target adjustment for Bayer demonstrates that analysts have recently begun to view the life sciences sector more favourably. The pharmaceutical and agrochemical group's strong start to the year has led to significantly improved prospects, and legal risks are now also viewed as more moderate. Finally, some good news for long-suffering investors in a geopolitically volatile environment. After all, there have not been any major upgrades in the sector for quite some time. When it comes to Novo Nordisk, however, experts remain divided on whether the earnings trend will turn positive again. Cutthroat competition in the weight-loss drug market is intense, putting pressure on margins. Buoyed by industry sentiment, Pfizer also saw its stock rise again. Time for a new tour of the sector. Where are the triggers?

    Read

    Commented by Nico Popp on May 20th, 2026 | 08:30 CEST

    Disruption in the Agricultural Sector: Why Corteva and Deere & Company Are Keeping an Eye on MustGrow Biologics

    • agritech
    • mustard
    • Agriculture
    • fertilizer
    • biologics
    • Digitization

    Created and published on behalf of MustGrow Biologics Corp.

    High energy prices, soil degradation, and consumer preference for organic products—the growing pressure on traditional agricultural chemicals poses an existential challenge to established market leaders. Those who do not embrace biological alternatives now risk falling behind due to growing regulatory requirements and increasing resistance. Driven by historically high energy prices, which make the production of conventional fertilizers more expensive, agricultural businesses are facing cost pressures. This economic predicament is becoming a catalyst for innovation: major corporations are investing billions in digital solutions and biologically active ingredients. We shed light on this trend and introduce exciting companies.

    Read

    Commented by Matthias Schomber on May 14th, 2026 | 07:55 CEST

    Bayer and BASF on a Performance High — and MustGrow Biologics as a Secret Weapon Against World Hunger!

    • agritech
    • Agriculture
    • fertilizer
    • Food
    • biologics

    Created and published on behalf of MustGrow Biologics Corp.

    The world's population is growing inexorably, and with it the demand for efficient—but above all sustainable—solutions in agriculture. While the German heavyweights Bayer and BASF have recently impressed markets with strong performance and further cemented their dominant positions, a smaller player is preparing to emerge from the slipstream of the industry giants and join the major leagues. Hardly anyone is likely to have this stock on their radar yet, but it would be worth at least adding it to the watchlist. MustGrow Biologics may have endured a difficult stretch on the stock market, but recent strategic decisions and regulatory successes suggest that the company could be delivering the right answers to pressing global food security challenges at exactly the right time. The market currently appears to be bottoming out, which could mark an attractive entry point for risk-tolerant investors before the biological agriculture trend gains further momentum. In this report, we examine the latest developments at these three companies in the battle for the farmland of the future.

    Read